“…Accordingly, the production and release of interleukin-1β, interleukin-6, and tumor necrosis factor-α were enhanced, and these biomarkers evolved into chronic inflammation and produced systemic inflammation (33). Furthermore, the increase of immune cell counts can elevate glucocorticoid levels, which can remodel the actin cytoskeleton of blood cells, impact cell morpho-rheological properties, and alter peripheral blood cell function (10).…”